Bio Medica Laboratories Ltd.

NSE: BMLL

Bio Medica Laboratories Live Share Price Today, Share Analysis and Chart

Name: Bio Medica Laboratories Ltd.: Is Infosys Ltd. worth buying?
Item: Bio Medica Laboratories Ltd.
Rating: 1.04991675
Author: Trendlyne DVM scores

aboutBio Medica Laboratories was incorporated on August 14, 2015. The company manufactures pharmaceutical injectable formulations for human and veterinary use, operating on a B2B contract manufacturing model. Its portfolio includes liquid and dry powder i... Read More

0.65(0.45%)

96,000

NSE Volume

High volume today

NSE 03 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

18.8 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

4Positive8Negative

33.3%Pass in checklist

045

100

Check P/E Buy Sell Zone

Strong Sell Zone

100.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Bio Medica Laboratories Stock Price Analysis

Day Price Range 0.4% 1 Day return	144.8 (LTP) 144.2146.2 LowHigh
Week Price Range -1.1% 1 Week return	144.8 (LTP) 144.2154.9 LowHigh
Month Price Range -9.2% 1 Month return	144.8 (LTP) 140.5174 LowHigh
52 Week Price Range 4.2% 1 Year return	144.8 (LTP) 101.5181 LowHigh

View full Price History/Seasonality

Competitors/Peers

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Bio Medica Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Bio Medica Laboratories Mar-2026 Annual Revenue is Rs 38 Cr which is growth of 0.3% YoY.
POSITIVE
Annual Net Profit Bio Medica Laboratories Mar-2026 Annual Net Profit is Rs 12 Cr which is growth of 20.3% YoY.

Bio Medica Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
SR_A Total Rev. Ann. ⌄	33.1%	24.4%	38.4	38.3	15.3	16.3	21.4	12.9
TotalOperatingRevenues_A Operating Rev. Ann.	33.2%	24.3%	38.3	38.3	15.3	16.2	21.2	12.9
OI_A Other Income Ann.	0%	-	0.1	0	0.1	0.1	0.2	0
OEXPNS_A Operating Exp. Ann.	11.1%	11.6%	19.9	23	9.7	14.5	19.5	11.5
OEXPNS_A Operating Exp. Ann.	11.1%	11.6%	19.9	23	9.7	14.5	19.5	11.5
OP_A Operating Profit Ann.	121.2%	67.4%	18.4	15.3	5.6	1.7	1.7	1.4
OPMPCT_A OPM Ann. %	65.7%	34%	47.81%	40.02%	36.17%	10.50%	7.84%	11.06%
TotalExpenses_A Total Exp. Ann. ⌄	12.8%	13%	22.7	25.2	11.8	15.8	20.6	12.3
OtherExpenses_A Other Exp. Ann.	26%	21.7%	2.4	1.9	1.3	1.2	1.1	0.9
EmployeeBenefitExpenses_A Employee Exp. Ann.	8.5%	10.4%	2.3	2	1.7	1.8	1.7	1.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	117.4%	67.6%	18.5	15.3	5.7	1.8	1.9	1.4
EBIDTPCT_A EBITDA Ann. margin %	64.6%	34%	48.16%	40.03%	36.79%	10.80%	8.83%	11.14%
INT_A Interest Ann.	33.4%	30.6%	1.9	1.2	1	0.8	0.8	0.5
DEP_A Depr.	21.6%	24.6%	0.9	1	1.1	0.5	0.3	0.3
PBT_A PBT Ann.	215.5%	92.1%	15.7	13.1	3.6	0.5	0.8	0.6
TAX_A Tax Ann.	242%	82.1%	4	3.4	0.9	0.1	0.2	0.2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	208.1%	96.4%	11.7	9.7	2.6	0.4	0.6	0.4
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	208.1%	96.4%	11.7	9.7	2.6	0.4	0.6	0.4
NETPCT_A NPM Ann. %	139.8%	55.1%	30.47%	25.32%	17.25%	2.21%	2.77%	3.39%
EPS_adj_A EPS Adj. latest Ann.	214.1%	87.6%	9.3	7.7	2.1	0.3	0.5	0.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

0.3%

2Y CAGR

58.4%

3Y CAGR

33.1%

5Y CAGR

24.4%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

20.6%

2Y CAGR

112.1%

3Y CAGR

208.1%

5Y CAGR

96.4%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

-13.5%

2Y CAGR

43.2%

3Y CAGR

11.1%

5Y CAGR

11.6%

Operating Expenses Annual Cr is falling faster than historical averages.

Bio Medica Laboratories Technical Analysis

Bio Medica Laboratories EMA & SMA

Bearish-7

0 bullish, 7 bearish

Bullish0

Bearish7

5 Day	147.3
10 Day	150.3
12 Day	151.2
20 Day	153.4

26 Day	154.2
50 Day	153.3
100 Day	146.4

Bio Medica Laboratories Delivery And Volume

Daily Avg. Delivery Volume %

03 Nov, 202699.0%

Week99.3%

Month92.0%

Bio Medica Laboratories Active Candlesticks

Harami Uptrend Homing Pigeon

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Bio Medica Laboratories Resistance and Support

145.10

Pivot

First Resistance	146
Second Resistance	147.2
Third Resistance	148.1

First Support	144.0
Second Support	143.1
Third Support	141.9

Day RSI	42.1
Day MACD	-3.1
Day MFI	36.6
Day MACD Signal Line	-1.4

Bio Medica Laboratories Beta

1 Month	0.0
1 Year	-

3 Month	-0.2
3 Year	-

Bio Medica Laboratories Price Change Analysis

↓-9.2%

Over 1 Month

LowHigh

140.5174

↓-8.9%

Over 3 Months

LowHigh

140.5181

↑4.2%

Over 6 Months

LowHigh

101.5181

↑4.2%

Over 1 Year

LowHigh

101.5181

Bio Medica Laboratories Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Mukesh Mehta	Promoter	4,256,316	33.9 %
Pine Oak Global Fund	Fii	260,000	2.1 %
Base Engineering Llp	Public	200,000	1.6 %
Tiger Strategies Fund -I	Dii	290,000	2.3 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Bio Medica Laboratories Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
JAYANT BABULAL BOKADIA	Bulk	Sell	27 Oct 2026	146	80,000	NSE
OSWAL ENERGIES LIMITED	Bulk	Purchase	27 Oct 2026	146	80,000	NSE
DIXIT JITENDRA BOKADIA	Bulk	Sell	26 Oct 2026	146	75,000	NSE
RATAN BABULAL BOKADIA	Bulk	Sell	26 Oct 2026	146	69,000	NSE
OSWAL ENERGIES LIMITED	Bulk	Purchase	26 Oct 2026	146	144,000	NSE
MAHABIR TRADEVENTURES LLP	Bulk	Sell	19 Aug 2026	159.60	118,000	NSE
RATHOD MANOJ CHHAGANLAL HUF	Bulk	Sell	18 Aug 2026	156.36	91,000	NSE
MAHABIR TRADEVENTURES LLP	Bulk	Sell	18 Aug 2026	153.50	116,000	NSE
RATHOD MANOJ CHHAGANLAL HUF	Bulk	Purchase	18 Aug 2026	156.37	46,000	NSE
AGGARWAL ATUL KASTURILAL	Bulk	Purchase	18 Aug 2026	153.50	116,000	NSE

All deals

Bio Medica Laboratories Corporate Actions

Bio Medica Laboratories Board Meetings

Bio Medica Laboratories past and upcoming board meetings.

#Ex-Date	Purpose	Notes
102 Sep 2026	Other business matters	To approve Notice of 11th AGM and authorize its issue to shareholders and other matters.
227 Jul 2026	Quarterly Results and Others	To consider and approve the financial results for the period ended March 31, 2026 and other business matters
322 Jun 2026	Others	To consider Other business matters.

All Corporate Actions

Bio Medica Laboratories - Company Profile

Bio Medica Laboratories Management Structure

Bio Medica Laboratories management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF	HISTORY & DETAILS
Mr. Santosh Kale	Chief Financial Officer	1.36	Mar 26
Khushi Gupta	Company Secretary,Compliance Officer	-	Mar 26

About

Website: www.biomedica.co.in

About the company - Business Profile

Bio Medica Laboratories was incorporated on August 14, 2015. The company manufactures pharmaceutical injectable formulations for human and veterinary use, operating on a B2B contract manufacturing model. Its portfolio includes liquid and dry powder injections produced under GMP and GLP-certified facilities equipped with advanced quality testing infrastructure

Bio Medica Laboratories FAQ

Bio Medica Laboratories today is trading in the green, up by 0.45% at ₹144.85.

Bio Medica Laboratories is currently trading up 0.45% on an intraday basis. In the past week the stock fell 1.06%. Stock has been down 8.87% in the past quarter and rose 4.21% in the past year. You can view this in the share price history/seasonality section.

Bio Medica Laboratories is listed on NSE with the ticker BMLL. It's currently trading on NSE at a share price of ₹144.85.

The market cap of Bio Medica Laboratories is ₹182.15 Cr. as of Nov 03, 2026.

Bio Medica Laboratories has never announced any dividend since the time of its listing on the NSE exchange.

Bio Medica Laboratories has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

Bio Medica Laboratories reported ₹43.11 Cr. in revenue, ₹11.89 Cr. in net profit, and ₹19.67 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for Bio Medica Laboratories.

The PE ratio of Bio Medica Laboratories is 15.32 as of Nov 03, 2026.

The PB ratio of Bio Medica Laboratories is 7.45 as of Nov 03, 2026.

There are no analyst reports for Bio Medica Laboratories.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Bio Medica Laboratories Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Bio Medica Laboratories Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Bio Medica Laboratories - Annual

Bio Medica Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Bio Medica Laboratories Mar-2026 Annual Revenue is Rs 38 Cr which is growth of 0.3% YoY.

Annual Net Profit Bio Medica Laboratories Mar-2026 Annual Net Profit is Rs 12 Cr which is growth of 20.3% YoY.

Bio Medica Laboratories Technical Analysis

Bio Medica Laboratories EMA & SMA

Bio Medica Laboratories Delivery And Volume

Bio Medica Laboratories Active Candlesticks

Bio Medica Laboratories Resistance and Support

Bio Medica Laboratories Beta

Bio Medica Laboratories Price Change Analysis

Bio Medica Laboratories Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Bio Medica Laboratories Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Bio Medica Laboratories Corporate Actions

Bio Medica Laboratories Board Meetings

Bio Medica Laboratories past and upcoming board meetings.

Bio Medica Laboratories - Company Profile

Bio Medica Laboratories Management Structure

Bio Medica Laboratories management structure with salaries, total experience, and qualifications.

About the company - Business Profile

Bio Medica Laboratories FAQ

How is Bio Medica Laboratories today?

Bio Medica Laboratories today is trading in the green, up by 0.45% at ₹144.85.

How has Bio Medica Laboratories performed historically?

Bio Medica Laboratories is currently trading up 0.45% on an intraday basis. In the past week the stock fell 1.06%. Stock has been down 8.87% in the past quarter and rose 4.21% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Bio Medica Laboratories on NSE and BSE exchanges?

Bio Medica Laboratories is listed on NSE with the ticker BMLL. It's currently trading on NSE at a share price of ₹144.85.

What is the market cap of Bio Medica Laboratories?

The market cap of Bio Medica Laboratories is ₹182.15 Cr. as of Nov 03, 2026.

When did Bio Medica Laboratories last pay a dividend, and what has its dividend history been?

Bio Medica Laboratories has never announced any dividend since the time of its listing on the NSE exchange.

Has Bio Medica Laboratories issued any bonus shares or share splits recently?

Bio Medica Laboratories has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

What do the financial statements and annual reports of Bio Medica Laboratories Indicate?

Bio Medica Laboratories reported ₹43.11 Cr. in revenue, ₹11.89 Cr. in net profit, and ₹19.67 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of Bio Medica Laboratories according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Bio Medica Laboratories.

What is the PE Ratio of Bio Medica Laboratories?

The PE ratio of Bio Medica Laboratories is 15.32 as of Nov 03, 2026.

What is the PB Ratio of Bio Medica Laboratories?

The PB ratio of Bio Medica Laboratories is 7.45 as of Nov 03, 2026.

Where can I check the latest Research Reports about Bio Medica Laboratories?

There are no analyst reports for Bio Medica Laboratories.

How can I be notified of real time alerts about Bio Medica Laboratories stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.